These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Baseline predictors of systemic lupus erythematosus flares: data from the combined placebo groups in the phase III belimumab trials. Petri MA, van Vollenhoven RF, Buyon J, Levy RA, Navarra SV, Cervera R, Zhong ZJ, Freimuth WW, BLISS-52 and BLISS-76 Study Groups. Arthritis Rheum; 2013 Aug; 65(8):2143-53. PubMed ID: 23754628 [Abstract] [Full Text] [Related]
13. The reduction of serum B-lymphocyte activating factor levels following quinacrine add-on therapy in systemic lupus erythematosus. Toubi E, Kessel A, Rosner I, Rozenbaum M, Paran D, Shoenfeld Y. Scand J Immunol; 2006 Apr; 63(4):299-303. PubMed ID: 16623930 [Abstract] [Full Text] [Related]
15. Hyperprolactinemia in males with systemic lupus erythematosus. Mok CC, Lau CS, Lee KW, Wong RW. J Rheumatol; 1998 Dec; 25(12):2357-63. PubMed ID: 9858430 [Abstract] [Full Text] [Related]
16. Reticulocytes bearing C4d as biomarkers of disease activity for systemic lupus erythematosus. Liu CC, Manzi S, Kao AH, Navratil JS, Ruffing MJ, Ahearn JM. Arthritis Rheum; 2005 Oct; 52(10):3087-99. PubMed ID: 16200588 [Abstract] [Full Text] [Related]
17. Correlation of the expression levels of BLyS and its receptors mRNA in patients with systemic lupus erythematosus. Ju S, Zhang D, Wang Y, Ni H, Kong X, Zhong R. Clin Biochem; 2006 Dec; 39(12):1131-7. PubMed ID: 17069785 [Abstract] [Full Text] [Related]
18. Serum albumin as a marker for disease activity in patients with systemic lupus erythematosus. Yip J, Aghdassi E, Su J, Lou W, Reich H, Bargman J, Scholey J, Gladman DD, Urowitz MB, Fortin PR. J Rheumatol; 2010 Aug 01; 37(8):1667-72. PubMed ID: 20516026 [Abstract] [Full Text] [Related]
19. Effect of disease activity and damage on quality of life in patients with systemic lupus erythematosus: a 2-year prospective study. Mok CC, Ho LY, Cheung MY, Yu KL, To CH. Scand J Rheumatol; 2009 Aug 01; 38(2):121-7. PubMed ID: 18991189 [Abstract] [Full Text] [Related]
20. Elevated B lymphocyte stimulator levels are associated with increased damage in an Irish systemic lupus erythematosus cohort. McCarthy EM, Lee RZ, Ní Gabhann J, Smith S, Cunnane G, Doran MF, Howard D, O'Connell P, Kearns G, Jefferies CA. Rheumatology (Oxford); 2013 Jul 01; 52(7):1279-84. PubMed ID: 23479724 [Abstract] [Full Text] [Related] Page: [Next] [New Search]